Article

Hyperprolactinemia as a rare cause of hypertension in chronic renal failure.

Department of Pediatric Nephrology, Baskent University, Ankara, Turkey.
Renal Failure (impact factor: 0.82). 04/2012; 34(6):792-4. DOI:10.3109/0886022X.2012.672313
Source: PubMed

ABSTRACT Chronic renal failure (CRF) is associated with a high risk for hypertension. An individualized treatment should be initiated after the diagnosis of hypertension and underlying etiology. Many metabolic and endocrinal abnormalities are encountered in CRF. We present an 11-year-old boy with CRF developing galactorrhea and hyperprolactinemia associated with α-methyldopa, defective dopaminergic control, and resistance to multi-antihypertensive therapy. Cabergoline, a dopamine receptor agonist, was effectively used in the treatment of hypertension. It is important to remember that sometimes treatment of an illness becomes the cause of this illness.

0 0
 · 
0 Bookmarks
 · 
37 Views
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.

Keywords

11-year-old boy
 
Chronic renal failure
 
CRF
 
defective dopaminergic control
 
dopamine receptor agonist
 
endocrinal abnormalities
 
etiology
 
hyperprolactinemia
 
individualized treatment